| Three Months Ended March 31, | Twelve Months Ended March 31, | ||||||||||||||
| 2023 | 2022 | 2023 | 2022 | ||||||||||||
| Research and development expenses, as reported | $ | 298.3 | $ | 259.1 | $ | 1,118.3 | $ | 989.1 | |||||||
| Share-based compensation expense | (22.0 | ) | (21.8 | ) | (83.1 | ) | (97.9 | ) | |||||||
| Acquisition-related | (0.2 | ) | (0.2 | ) | (0.8 | ) | (0.8 | ) | |||||||
| Non-GAAP research and development expenses | $ | 276.1 | $ | 237.1 | $ | 1,034.4 | $ | 890.4 | |||||||
| GAAP research and development expenses as a percentage of net sales | 13.4 | % | 14.0 | % | 13.3 | % | 14.5 | % | |||||||
| Non-GAAP research and development expenses as a percentage of net sales | 12.4 | % | 12.9 | % | 12.3 | % | 13.1 | % | |||||||
Microchip Technology Announces Record Financial Results for Fourth Quarter and Fiscal Year 2023
 |  | More IC News
|
|
RECONCILIATION OF GAAP RESEARCH AND DEVELOPMENT EXPENSES TO NON-GAAP RESEARCH AND DEVELOPMENT EXPENSES
RELATED NEWS
